Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RBC Capital Maintains Outperform on UnitedHealth Group, Lowers Price Target to $555

Author: Benzinga Newsdesk | April 17, 2024 10:59am
RBC Capital analyst Ben Hendrix maintains UnitedHealth Group (NYSE:UNH) with a Outperform and lowers the price target from $596 to $555.

Posted In: UNH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist